BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 23.07.2001

Hematology and Pathology Devices; Reclassification of Automated Differential Cell Counters; Correction

The Food and Drug Administration (FDA) is correcting a proposed rule that appeared in the Federal Register of May 9, 2001 (66 FR 23634). The document proposes to reclassify from class III (premarket approval) to class II (special controls) the automated differential cell counter (ADCC). The document published inadvertently with the incorrect docket number. This document corrects that error.

Source: Federal Register — Food and Drug AdministrationOpen original release →